B cell response during infection with the MAT a and MAT alpha mating types of Cryptococcus neoformans

Microbes and Infection

Volumn 7, Issue 1, 2005, Pages 118-125

  Santos Rodrigues, Adila Regina T ^a   Heise, Norton ^a   Previato, José Osvaldo ^a   Mendonça Previato, Lucia ^a   Peçanha, Ligia M T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

B lymphocytes; Cryptococcus neoformans; Immunoglobulin; Mating type; Polysaccharide; Virulence

Indexed keywords

FUNGUS VACCINE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BRAIN INFECTION; CELL POPULATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; EXPERIMENTAL INFECTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FUNGAL VIRULENCE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; MALE; MATING; MOUSE; MOUSE STRAIN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SPLEEN CELL; STRAIN DIFFERENCE;

EID: 15944392802     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.09.009     Document Type: Article

References (54)

1. J.R. Perfect, and A. Casadevall Cryptococcosis Infect. Dis. Clin. North Am 16 2002 837 874
2. A. Casadevall, and J.R. Perfect Cryptococcus neoformans 1998 ASM Press Washigton, DC p. 541
3. K.J. Kwon-Chung Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans Mycology 68 1976 942 946
4. C.M. McClelland, Y.C. Chang, A. Varma, and K.J. Kwon-Chung Uniqueness of the mating system in Cryptococcus neoformans Trends Microbiol 12 2004 208 212
5. N. Madrenys, C. De Vroey, C. Raes-Wuytack, and J.M. Torres-Rodriguez Identification of the perfect state of Cryptococcus neoformans from 195 clinical isolates including 84 from AIDS patients Mycopathologia 123 1993 65 69
6. K.J. Kwong-Chung, and J.E. Bennett Distribution of a and alpha mating types of C. neoformans among natural and clinical isolates Am. J. Epidemiol. 108 1978 337 340
7. K.J. Kwong-Chung, J.C. Edman, and B.L. Wickes Genetic association of mating types and virulence in C. neoformans Infect. Immun. 60 1992 602 605
8. Y.C. Chang, L.A. Penoyer, and K.J. Kwon-Chung The second STE12 homologue of Cryptococcus neoformans is MAT a-specific and plays an important role in virulence Proc. Natl. Acad. Sci. USA 98 2001 3258 3263
9. Y.C. Chang, B.L. Wickles, G.F. Miller, L.A. Penoyer, and K.J. Kwong-Chung Cryptococcus neoformans STE12 alpha regulates virulence but is not essential for mating J. Exp. Med. 191 2000 871 881
10. S.M. Levitz Macrophage interactions with Cryptococcus neoformans ASM News 64 1998 639 693
11. J.A. Wilder, G.K. Olson, Y.C. Chang, K.J. Kwon-Chung, and M.F. Lipscomb Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection Am. J. Respir. Cell. Mol. Biol 26 2002 306 314
12. K. Nielsen, G.M. Cox, P. Wang, D.L. Toffaletti, J.R. Perfect, and J. Heitman Sexual cycle of Cryptococcus neoformans var. grubbi and virulence of congenic a and alpha isolates Infect. Immun. 71 2003 4831 4841
13. O. Zaragoza, B.C. Fries, and A. Casadevall Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2) Infect. Immun. 71 2003 6155 6164
14. N. Lendvai, A. Casadevall, A. Liang, D.L. Goldman, J. Mukherjee, and L. Zuckier Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide J. Infect. Dis 177 1998 1647 1659
15. A. Vecchiarelle, and A. Casadevall Antibody mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity Res. Immunol. 149 1998 321 333
16. J.B. Sundstrom, and R. Cherniak T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A Infect. Immun. 61 1993 1340 1345
17. F. Dromer, P. Yeni, and J. Charriere Genetic control of the humoral response to cryptococcal polysaccharide in mice Immunogenetics 28 1988 417 424
18. L.L. Ma, J.C. Spurrell, J.F. Wang, G.G. Neely, S. Epelman, A.M. Krensky, and C.H. Mody CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15 J. Immunol. 169 2002 5787 5795
19. R.M. Sym, J.C. Spurrell, E.K. Amankwah, F.H. Green, and C.H. Mody Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes Infect. Immun 70 2002 5972 5981
20. S.K. Bauman, G.B. Huffnagle, and J.W. Murphy Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response Infect. Immun 71 2003 68 74
21. D. Pietrella, P. Lupo, S. Perito, P. Mosci, F. Bistoni, and A. Vecchiarelli Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection FEMS Immunol. Med. Microbiol 40 2004 63 70
22. G. Marquis, S. Montplaisir, M. Pelletier, S. Mousseau, and P. Auger Genetic resistance to murine cryptococcosis: the beige mutation (Chediak-Higashi syndrome) in mice Infect. Immun. 47 1985 288 293
23. S. Neuville, O. Lortholary, and F. Dromer Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome? Infect. Immun. 68 2000 3724 3726
24. A. Casadevall, M. Feldmesser, and L.A. Pirofski Induced humoral immunity and vaccination against major human fungal pathogens Curr. Opin. Microbiol 5 2002 386 391
25. R.W. Maitta, K. Datta, Q. Chang, R.X. Luo, B. Witover, K. Subramaniam, and L.A. Pirofski Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles Infect. Immun. 72 2004 4810 4818
26. M. Feldmesser, A. Mednick, and A. Casadevall Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses Infect. Immun 70 2002 1571 1580
27. M. Feldmesser, J. Rivera, Y. Kress, T.R. Kozel, and A. Casadevall Antibody interactions with the capsule of Cryptococcus neoformans Infect. Immun. 68 2000 3642 3650
28. R. Yuan, A. Casadevall, G. Spira, and M.D. Scharff Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody J. Immunol. 154 1995 1810 1816
29. S. Mukherjee, S.C. Lee, and A. Casadevall Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages Infect. Immun. 63 1995 573 579
30. J. Mukherjee, G. Nussbaum, M.D. Scharff, and A. Casadevall Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell J. Exp. Med. 181 1995 405 409
31. A. Nakouzi, P. Valadon, J. Nosanchuk, N. Green, and A. Casadevall Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies Infect. Immun 69 2001 3398 4309
32. G.R. McLean, M. Torres, N. Elguezabal, A. Nakouzi, and A. Casadevall Isotype can affect the fine specificity of an antibody for a polysaccharide antigen J. Immunol 169 2002 1379 1386
33. G.B. Huffnagle, J.L. Yates, and M.F. Lipscomb Immunity to a pulmonary Cryptotoccus neoformnas infection requires both CD4+ and CD8+ T cells J. Exp. Med. 173 1991 793 800
34. G.B. Huffnagle, J.L. Yates, and M.F. Lipscomb T cell mediated immunity in the lung: a Cryptococcus neofornans pulmonary infection model using SCID and athymic nude mice Infect. Immun. 59 1991 1423 1423
35. G.B. Huffnagle, G.H. Chen, J.L. Curtis, R.A. McDonald, R.M. Strieter, and G.B. Toews Down-regulation of the afferent phase of T cell-mediated immunity and pulmonary inflammation by a high melanin-producing strain of C. neoformans J. Immunol. 155 1995 3507 3516
36. K.A. Hoag, N.E. Street, G.B. Huffnagle, and M.F. Lipscomb Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice Am. J. Respir. Cell Mol. Biol. 4 1995 487 495
37. G.B. Huffnagle, M.B. Boyde, N.E. Street, and M.F. Lipscomb IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57Bl/6) J. Immunol. 160 1998 2393 2400
38. R. Blackstock, K.L. Buchanan, A.M. Adesina, and J.W. Murphy Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates Infect. Immun. 67 1999 3601 3609
39. R. Cherniak, E. Reiss, and S.H. Turner A galactoxylomanan antigen of Cryptococcus neoforman serotype A Carbohydr. Res. 103 1982 239 250
40. J.J. Mond, K. Hunter, J.J. Kenny, F.D. Finkelman, and K. Witerspoon 8-Mercaptoguanosine mediated enhancement of in vivo IgG1, IgG2 and IgG3 antibody response to polysaccharide antigens in normal da xid mice Immunopharmacology 18 1989 205 211
41. E. Lagasse, and I.L. Weissman Flow cytometric identification of murine neutrophils and monocytes J. Immunol. Methods 197 1996 139 150
42. A.M. Oliver, F. Martin, G.L. Gartland, R.H. Carter, and J.F. Kearney Marginal zone B cells exibit unique activation, proliferation and immunoglobulin secretory responses Eur. J. Immunol. 27 1997 2366 2374
43. C.P. Taborda, and A. Casadevall Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments J. Immunol 166 2001 2100 2107
44. L. Romani, and D.H. Howard Mechanisms of resistance to fungal infections Curr. Opin. Immun. 7 1995 517 523
45. A. Casadevall Antibody immunity and invasive fungal infections Infect. Immun. 63 1995 4211 4218
46. F.E. Coenjaerts, A. Walenkamp, P.N. Mwinzi, J. Scharringa, H.A. Dekker, J.A. Van Stripj, R. Cherniak, and A.I. Hoepelman Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization J. Immunol 167 2001 3988 3995
47. M.M. Lipovsky, L. Tsenov, F.E. Coenjaerts, G. Kaplan, R. Cherniak, and A.L. Hoepelman Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis J. Neuroimmunol. 111 2000 10 14
48. P.M. Ellerbroek, L.H. Ulfman, A.I. Hoepelman, and F.E. Coenjaerts Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endothelium Cell. Microbiol 6 2004 581 592
49. A.M. Oliver, F. Martin, and F.J. Kearney IgMhigh CD21 high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells J. Immunol. 162 1999 7198 7207
50. F. Martin, and J.F. Kearney Marginal-zone B cells Nat. Rev. Immunol 2 2002 323 335
51. B. Schiemann, J.L. Gommerman, K. Vora, T.G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M.L. Scott An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway Science 293 2001 2111 2114
52. L.S. Chiapello, M.P. Aoki, H.R. Rubinstein, and D.T. Masih Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans Med. Mycol 41 2003 347 353
53. A.H. Achtman, M. Khan, I.M.C. MacLennan, and J. Langhorne Plasmodium chabaudi chabaudi infection in mice induces strong B cell response and striking but temporary changes in splenic cell distribution J. Immunol 171 2003 317 324
54. R.R. Hardy, and K. Hayakawa B cell development pathways Annu. Rev. Immunol 19 2001 595 621